Tiber Creek’s Health Policy Spotlight: FDA Regulation of Direct-to-Consumer Pharmaceutical Ads

Last fall, the Food and Drug Administration announced it would prioritize increased enforcement against misleading or false direct-to-consumer (DTC) pharmaceutical advertising. The agency also stated it would change a provision related to how risk and safety information is provided in broadcast pharmaceutical ads. We’ve broken down FDA’s regulatory authority and recent actions in our two-page primer on FDA Regulation of DTC Pharmaceutical Advertising, here.